Title : Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer.

Pub. Date : 2020 Jan-Dec

PMID : 32406319






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The level of interleukin 6 was reduced in desloratadine-treated cells, while upregulation of interleukin 6 significantly abolished the anticancer activity of desloratadine in cell invasion and Bcl-2, Bax, Beclin1, LC3-I/II, N-cadherin, and E-cadherin expression in EJ cells. desloratadine interleukin 6 Homo sapiens
2 The level of interleukin 6 was reduced in desloratadine-treated cells, while upregulation of interleukin 6 significantly abolished the anticancer activity of desloratadine in cell invasion and Bcl-2, Bax, Beclin1, LC3-I/II, N-cadherin, and E-cadherin expression in EJ cells. desloratadine interleukin 6 Homo sapiens
3 Taken together, our data suggest a potential anticancer activity of desloratadine on cell growth and invasion for bladder cancer, which may be mediated by diminishing the epithelial-to-mesenchymal transition and interleukin 6. desloratadine interleukin 6 Homo sapiens